Owlet (NYSE:OWLT – Get Free Report) and Profound Medical (NASDAQ:PROF – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation and risk.
Earnings & Valuation
This table compares Owlet and Profound Medical”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Owlet | $105.70 million | 1.28 | -$39.68 million | ($0.75) | -6.16 |
| Profound Medical | $16.10 million | 16.93 | -$42.57 million | ($0.93) | -8.00 |
Owlet has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a summary of recent ratings for Owlet and Profound Medical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Owlet | 1 | 1 | 3 | 0 | 2.40 |
| Profound Medical | 1 | 0 | 1 | 1 | 2.67 |
Owlet presently has a consensus target price of $15.00, indicating a potential upside of 224.61%. Profound Medical has a consensus target price of $11.50, indicating a potential upside of 54.57%. Given Owlet’s higher possible upside, equities analysts plainly believe Owlet is more favorable than Profound Medical.
Risk & Volatility
Owlet has a beta of 2.17, suggesting that its share price is 117% more volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.79, suggesting that its share price is 21% less volatile than the S&P 500.
Institutional & Insider Ownership
72.6% of Owlet shares are owned by institutional investors. Comparatively, 47.9% of Profound Medical shares are owned by institutional investors. 36.2% of Owlet shares are owned by company insiders. Comparatively, 1.5% of Profound Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Profitability
This table compares Owlet and Profound Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Owlet | -8.61% | -601.24% | -15.96% |
| Profound Medical | -137.51% | -59.57% | -47.87% |
Summary
Owlet beats Profound Medical on 11 of the 15 factors compared between the two stocks.
About Owlet
Owlet develops connected baby-monitoring products designed to give parents information about an infant’s sleep and well-being. Its offerings include the Dream Sock, a wearable monitor that tracks sleep-related readings, and Owlet Cam cameras, which provide video and audio monitoring through the company’s app. The company’s products combine wearable sensors, cameras and mobile software to help families monitor their babies at home. The Dream Sock has FDA clearance to monitor pulse rate and oxygen saturation in infants from 1 to 18 months of age.
About Profound Medical
Profound Medical Corp. is a Canadian medical-device company that develops MRI-guided therapies using focused ultrasound. Its systems combine magnetic resonance imaging with ultrasound energy to help clinicians target and treat tissue without conventional open surgery. The company’s TULSA-PRO system is designed to ablate prostate tissue. It also offers Sonalleve, an MRI-guided focused-ultrasound platform developed for applications including the treatment of uterine fibroids and the palliation of pain from bone metastases.
Receive News & Ratings for Owlet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owlet and related companies with MarketBeat.com's FREE daily email newsletter.
